Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

The Lancet Oncology, 1470-2045

Journal

  1. 2020
  2. Published

    Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

    Powles, T., van der Heijden, M. S., Castellano, D., Galsky, M. D., Loriot, Y., Petrylak, D. P., Ogawa, O., Park, S. H., Lee, J-L., De Giorgi, U., Bögemann, M., Bamias, A., Eigl, B. J., Gurney, H., Mukherjee, S. D., Fradet, Y., Skoneczna, I., Tsiatas, M., Novikov, A., Suárez, C., Fay, A. P., Duran, I., Necchi, A., Wildsmith, S., He, P., Angra, N., Gupta, A. K., Levin, W., Bellmunt, J., DANUBE study investigators & Pappot, H., Dec 2020, In: The Lancet Oncology. 21, 12, p. 1574-1588 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply

    Subbiah, V., Lassen, U., Gasal, E., Burgess, P. & Wainberg, Z. A., Nov 2020, In: Lancet Oncology. 21, 11, p. e516

    Research output: Contribution to journalComment/debateResearchpeer-review

  4. Published

    Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

    Subbiah, V., Lassen, U., Élez, E., Italiano, A., Curigliano, G., Javle, M., de Braud, F., Prager, G. W., Greil, R., Stein, A., Fasolo, A., Schellens, J. H. M., Wen, P. Y., Viele, K., Boran, A. D., Gasal, E., Burgess, P., Ilankumaran, P. & Wainberg, Z. A., Sep 2020, In: The Lancet Oncology. 21, 9, p. 1234-1243 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

    Al-Sawaf, O., Zhang, C., Tandon, M., Sinha, A., Fink, A-M., Robrecht, S., Samoylova, O., Liberati, A. M., Pinilla-Ibarz, J., Opat, S., Sivcheva, L., Le Dû, K., Fogliatto, L. M., Niemann, C. U., Weinkove, R., Robinson, S., Kipps, T. J., Tausch, E., Schary, W., Ritgen, M., Wendtner, C-M., Kreuzer, K-A., Eichhorst, B., Stilgenbauer, S., Hallek, M. & Fischer, K., Sep 2020, In: The Lancet Oncology. 21, 9, p. 1188-1200 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    New approaches to cancer care in a COVID-19 world

    Butler, J., Finley, C., Norell, C. H., Harrison, S., Bryant, H., Achiam, M. P., Altman, A. D., Baxter, N., Bentley, J., Cohen, P. A., Chaudry, M. A., Dixon, E., Farrell, R., Fegan, S., Hashmi, S., Hogdall, C., Jenkins, J. T., Kwon, J., Mala, T., McNally, O., Merrett, N., Nelson, G., Nordin, A., Park, J., Porter, G., Reynolds, J., Schieman, C., Schnack, T., Spigelman, A., Svendsen, L. B., Sykes, P. & Thomas, R., Jul 2020, In: The Lancet Oncology. 21, 7, p. e339-e340

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

    Lassen, U., Feb 2020, In: Lancet Oncology. 21, 2, p. 193-194 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  8. 2019
  9. Published

    Access to radiotherapy among circumpolar Inuit populations

    Chan, J., Friborg, J., Chernov, M., Cherkashin, M., Grau, C., Brundage, M. & Slotman, B., Oct 2019, In: Lancet Oncology. 20, 10, p. e590-e600

    Research output: Contribution to journalReviewpeer-review

  10. Published

    Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

    AVANOVA investigators, Oct 2019, In: Lancet Oncology. 20, 10, p. 1409-1419 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Combining PARP inhibition with PD-1 inhibitors

    Lassen, U., Sep 2019, In: Lancet Oncology. 20, 9, p. 1196-1198 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

    TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, Jun 2019, In: Lancet Oncology. 20, 6, p. 862-876 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Meta-analysis of penile cancer: conceptual interpretations - Authors' reply

    Albieri, V., Olesen, T. B., Sand, F. L., Rasmussen, C. L., Toft, B. G., Norrild, B., Munk, C. & Kjær, S. K., Mar 2019, In: Lancet Oncology. 20, 3, p. e126

    Research output: Contribution to journalComment/debateResearchpeer-review

  14. Published

    Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial

    de Bono, J. S., Concin, N., Hong, D. S., Thistlethwaite, F. C., Machiels, J-P., Arkenau, H-T., Plummer, R., Jones, R. H., Nielsen, D., Windfeld, K., Ghatta, S., Slomovitz, B. M., Spicer, J. F., Yachnin, J., Ang, J. E., Mau-Sørensen, P. M., Forster, M. D., Collins, D., Dean, E., Rangwala, R. A. & Lassen, U., Mar 2019, In: Lancet Oncology. 20, 3, p. 383-393 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    A European paediatric cancer mission: aspiration or reality?

    Kearns, P. R., Vassal, G., Ladenstein, R., Schrappe, M., Biondi, A., Blanc, P., Eggert, A., Kienesberger, A., Kozhaeva, O., Pieters, R. & Schmiegelow, K., 2019, In: Lancet Oncology. 20, 9, p. 1200-1202 3 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  16. Published

    Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis

    Olesen, T. B., Sand, F. L., Rasmussen, C. L., Albieri, V., Toft, B. G., Norrild, B., Munk, C. & Kjær, S. K., 2019, In: Lancet Oncology. 20, 1, p. 145-158 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial

    Oscarsson, N., Müller, B., Rosén, A., Lodding, P., Mölne, J., Giglio, D., Hjelle, K. M., Vaagbø, G., Hyldegaard, O., Vangedal, M., Salling, L., Kjellberg, A., Lind, F., Ettala, O., Arola, O. & Seeman-Lodding, H., 2019, In: Lancet Oncology. 20, 11, p. 1602-1614 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Solid organ transplantations in childhood cancer survivors: an unrealised research potential

    Winther, J. F., Schmidt, I. M. & Poggio, E. D., 2019, In: Lancet Oncology. 20, 10, p. 1337-1338 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  19. 2018
  20. Published

    Maternal use of hormonal contraception and risk of childhood leukaemia - Authors' reply

    Hargreave, M., Mørch, L. S., Andersen, K. K., Winther, J. F., Schmiegelow, K. & Kjaer, S. K., Dec 2018, In: Lancet Oncology. 19, 12, p. e659

    Research output: Contribution to journalComment/debateResearchpeer-review

  21. Published

    Integration of oncology and palliative care: a Lancet Oncology Commission

    Kaasa, S., Loge, J. H., Aapro, M., Albreht, T., Anderson, R., Bruera, E., Brunelli, C., Caraceni, A., Cervantes, A., Currow, D. C., Deliens, L., Fallon, M., Gómez-Batiste, X., Grotmol, K. S., Hannon, B., Haugen, D. F., Higginson, I. J., Hjermstad, M. J., Hui, D., Jordan, K., Kurita, G. P., Larkin, P. J., Miccinesi, G., Nauck, F., Pribakovic, R., Rodin, G., Sjøgren, P., Stone, P., Zimmermann, C. & Lundeby, T., Nov 2018, In: Lancet Oncology. 19, 11, p. e588-e653

    Research output: Contribution to journalReviewpeer-review

  22. Published

    Maternal use of hormonal contraception and risk of childhood leukaemia: a nationwide, population-based cohort study

    Hargreave, M., Mørch, L. S., Andersen, K. K., Winther, J. F., Schmiegelow, K. & Kjaer, S. K., Oct 2018, In: Lancet Oncology. 19, 10, p. 1307-1314 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

    Oza, A. M., Matulonis, U. A., Malander, S., Hudgens, S., Sehouli, J., Del Campo, J. M., Berton-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, B., Tinker, A. V., Hilpert, F., Vázquez, I. P., D'Hondt, V., Benigno, B., Provencher, D., Buscema, J., Agarwal, S. & Mirza, M. R., Aug 2018, In: Lancet Oncology. 19, 8, p. 1117-1125 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

    Waszak, S. M., Northcott, P. A., Buchhalter, I., Robinson, G. W., Sutter, C., Groebner, S., Grund, K. B., Brugières, L., Jones, D. T. W., Pajtler, K. W., Morrissy, A. S., Kool, M., Sturm, D., Chavez, L., Ernst, A., Brabetz, S., Hain, M., Zichner, T., Segura-Wang, M., Weischenfeldt, J., Rausch, T., Mardin, B. R., Zhou, X., Baciu, C., Lawerenz, C., Chan, J. A., Varlet, P., Guerrini-Rousseau, L., Fults, D. W., Grajkowska, W., Hauser, P., Jabado, N., Ra, Y-S., Zitterbart, K., Shringarpure, S. S., De La Vega, F. M., Bustamante, C. D., Ng, H-K., Perry, A., MacDonald, T. J., Hernáiz Driever, P., Bendel, A. E., Bowers, D. C., McCowage, G., Chintagumpala, M. M., Cohn, R., Hassall, T., Fleischhack, G., Eggen, T., Wesenberg, F., Feychting, M., Lannering, B., Schüz, J., Johansen, C., Andersen, T. V., Röösli, M., Kuehni, C. E., Grotzer, M., Kjaerheim, K., Monoranu, C. M., Archer, T. C., Duke, E., Pomeroy, S. L., Shelagh, R., Frank, S., Sumerauer, D., Scheurlen, W., Ryzhova, M. V., Milde, T., Kratz, C. P., Samuel, D., Zhang, J., Solomon, D. A., Marra, M., Eils, R., Bartram, C. R., von Hoff, K., Rutkowski, S., Ramaswamy, V., Gilbertson, R. J., Korshunov, A., Taylor, M. D., Lichter, P., Malkin, D., Gajjar, A., Korbel, J. O. & Pfister, S. M., 1 Jun 2018, In: Lancet Oncology. 19, 6, p. 785-798

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

    Colleoni, M., Luo, W., Karlsson, P., Chirgwin, J., Aebi, S., Jerusalem, G., Neven, P., Hitre, E., Graas, M-P., Simoncini, E., Kamby, C., Thompson, A., Loibl, S., Gavilá, J., Kuroi, K., Marth, C., Müller, B., O'Reilly, S., Di Lauro, V., Gombos, A., Ruhstaller, T., Burstein, H., Ribi, K., Bernhard, J., Viale, G., Maibach, R., Rabaglio-Poretti, M., Gelber, R. D., Coates, A. S., Di Leo, A., Regan, M. M., Goldhirsch, A. & SOLE Investigators, 2018, In: Lancet Oncology. 19, 1, p. 127-138

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database

    Brok, J., Lopez-Yurda, M., Tinteren, H. V., Treger, T. D., Furtwängler, R., Graf, N., Bergeron, C., van den Heuvel-Eibrink, M. M., Pritchard-Jones, K., Olsen, Ø. E., de Camargo, B., Verschuur, A. & Spreafico, F., 2018, In: Lancet Oncology. 19, 8, p. 1072-1081 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. 2017
  28. Published

    European position statement on lung cancer screening

    Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C. P., Bastarrika, G., Sverzellati, N., Mascalchi, M., Delorme, S., Baldwin, D. R., Callister, M. E., Becker, N., Heuvelmans, M. A., Rzyman, W., Infante, M. V., Pastorino, U., Pedersen, J. H., Paci, E., Duffy, S. W., de Koning, H. & Field, J. K., Dec 2017, In: Lancet Oncology. 18, 12, p. e754-e766

    Research output: Contribution to journalReviewpeer-review

  29. Published

    Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study

    Wolthers, B. O., Frandsen, T. L., Baruchel, A., Attarbaschi, A., Barzilai, S., Colombini, A., Escherich, G., Grell, K., Inaba, H., Kovacs, G., Liang, D-C., Mateos, M., Mondelaers, V., Möricke, A., Ociepa, T., Samarasinghe, S., Silverman, L. B., van der Sluis, I. M., Stanulla, M., Vrooman, L. M., Yano, M., Zapotocka, E., Schmiegelow, K. & Ponte di Legno Toxicity Working Group, Sep 2017, In: Lancet Oncology. 18, 9, p. 1238-1248 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. Published

    Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy? - Authors' reply

    Schmiegelow, K., Nielsen, S. N. & Grell, K., Jun 2017, In: Lancet Oncology. 18, 6, p. e292

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial

    Nielsen, S. N., Grell, K., Nersting, J., Abrahamsson, J., Lund, B., Kanerva, J., Jónsson, Ó. G., Vaitkeviciene, G., Pruunsild, K., Hjalgrim, L. L. & Schmiegelow, K., Apr 2017, In: Lancet Oncology. 18, 4, p. 515-524 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    The drama of prostate cancer diagnostics - Authors' reply

    Iversen, P., Røder, M. A. & Klemann, N., Mar 2017, In: Lancet Oncology. 18, 3, p. e133

    Research output: Contribution to journalJournal articleResearch

  33. Published
  34. Published

    Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Martin, M., Holmes, F. A., Ejlertsen, B., Delaloge, S., Moy, B., Iwata, H., von Minckwitz, G., Chia, S. K. L., Mansi, J., Barrios, C. H., Gnant, M., Tomašević, Z., Denduluri, N., Šeparović, R., Gokmen, E., Bashford, A., Ruiz Borrego, M., Kim, S-B., Jakobsen, E. H., Ciceniene, A., Inoue, K., Overkamp, F., Heijns, J. B., Armstrong, A. C., Link, J. S., Joy, A. A., Bryce, R., Wong, A., Moran, S., Yao, B., Xu, F., Auerbach, A., Buyse, M., Chan, A. & ExteNET Study Group, 2017, In: Lancet Oncology. 18, 12, p. 1688-1700

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. 2016
  36. Published

    Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus

    Schmiegelow, K., Attarbaschi, A., Barzilai, S., Escherich, G., Frandsen, T. L., Halsey, C., Hough, R., Jeha, S., Kato, M., Liang, D-C., Mikkelsen, T. S., Möricke, A., Niinimäki, R., Piette, C., Putti, M. C., Raetz, E., Silverman, L. B., Skinner, R., Tuckuviene, R., van der Sluis, I., Zapotocka, E. & Ponte di Legno toxicity working group, Jun 2016, In: Lancet Oncology. 17, 6, p. e231-9

    Research output: Contribution to journalJournal articleResearchpeer-review

  37. Published

    Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

    O'Sullivan, B., Huang, S. H., Su, J., Garden, A. S., Sturgis, E. M., Dahlstrom, K., Lee, N., Riaz, N., Pei, X., Koyfman, S. A., Adelstein, D., Burkey, B. B., Friborg, J., Kristensen, C. A., Gothelf, A. B., Hoebers, F., Kremer, B., Speel, E-J., Bowles, D. W., Raben, D., Karam, S. D., Yu, E. & Xu, W., Apr 2016, In: Lancet Oncology. 17, 4, p. 440-51 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published

    Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Chan, A., Delaloge, S., Holmes, F. A., Moy, B., Iwata, H., Harvey, V. J., Robert, N. J., Silovski, T., Gokmen, E., von Minckwitz, G., Ejlertsen, B., Chia, S. K. L., Mansi, J., Barrios, C. H., Gnant, M., Buyse, M., Gore, I., Smith, J., Harker, G., Masuda, N., Petrakova, K., Zotano, A. G., Iannotti, N., Rodriguez, G., Tassone, P., Wong, A., Bryce, R., Ye, Y., Yao, B., Martin, M. & ExteNET Study Group, Mar 2016, In: Lancet Oncology. 17, 3, p. 367-77 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

    Bois, A. D., Kristensen, G., Ray-Coquard, I., Reuss, A., Pignata, S., Colombo, N., Denison, U., Vergote, I., Del Campo, J. M., Ottevanger, P., Heubner, M., Minarik, T., Sevin, E., de Gregorio, N., Bidziński, M., Pfisterer, J., Malander, S., Hilpert, F., Mirza, M. R., Scambia, G., Meier, W., Nicoletto, M. O., Bjørge, L., Lortholary, A., Sailer, M. O., Merger, M., Harter, P. & AGO Study Group led Gynecologic Cancer Intergroup (GCIG)/European Network of Gynaecologic Oncology Trials Groups (ENGOT) Intergroup Consortium, Jan 2016, In: Lancet Oncology. 17, 1, p. 78–89

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. 2015
  41. Published

    Classification of treatment-related mortality in children with cancer: a systematic assessment

    Alexander, S., Pole, J. D., Gibson, P., Lee, M., Hesser, T., Chi, S. N., Dvorak, C. C., Fisher, B., Hasle, H., Kanerva, J., Möricke, A., Phillips, B., Raetz, E., Rodriguez-Galindo, C., Samarasinghe, S., Schmiegelow, K., Tissing, W., Lehrnbecher, T., Sung, L. & International Pediatric Oncology Mortality Classification Group, Dec 2015, In: Lancet Oncology. 16, 16, p. e604-10

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

    Oza, A. M., Cook, A. D., Pfisterer, J., Embleton, A., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Park-Simon, T-W., Rustin, G., Joly, F., Mirza, M. R., Plante, M., Quinn, M., Poveda, A., Jayson, G. C., Stark, D., Swart, A. M., Farrelly, L., Kaplan, R., Parmar, M. K. B., Perren, T. J. & ICON7 trial investigators, Aug 2015, In: Lancet Oncology. 16, 8, p. 928-36 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. Published

    Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

    Machiels, J-P. H., Haddad, R. I., Fayette, J., Licitra, L. F., Tahara, M., Vermorken, J. B., Clement, P. M., Gauler, T. C., Cupissol, D., Grau, J. J., Guigay, J., Caponigro, F., de Castro, G., de Souza Viana, L., Keilholz, U., Del Campo, J. M., Cong, X. J., Ehrnrooth, E., Cohen, E. E. W., LUX-H&N 1 investigators (Lena Specht, member) & Specht, L., May 2015, In: Lancet Oncology. 16, 5, p. 583-94 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. Published

    Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

    Farooqui, M. Z. H., Valdez, J., Martyr, S., Aue, G., Saba, N., Niemann, C. U., Herman, S. E. M., Tian, X., Marti, G., Soto, S., Hughes, T. E., Jones, J., Lipsky, A., Pittaluga, S., Stetler-Stevenson, M., Yuan, C., Lee, Y. S., Pedersen, L. B., Geisler, C. H., Calvo, K. R., Arthur, D. C., Maric, I., Childs, R., Young, N. S. & Wiestner, A., Feb 2015, In: Lancet Oncology. 16, 2, p. 169-76 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  45. Published

    Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

    Sternberg, C. N., Skoneczna, I., Kerst, J. M., Albers, P., Fossa, S. D., Agerbaek, M., Dumez, H., de Santis, M., Théodore, C., Leahy, M. G., Chester, J. D., Verbaeys, A., Daugaard, G., Wood, L., Witjes, J. A., de Wit, R., Geoffrois, L., Sengelov, L., Thalmann, G., Charpentier, D., Rolland, F., Mignot, L., Sundar, S., Symonds, P., Graham, J., Joly, F., Marreaud, S., Collette, L., Sylvester, R. & European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group, Jan 2015, In: Lancet Oncology. 16, 1, p. 76-86 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. 2014
  47. Published

    Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

    San-Miguel, J. F., Hungria, V. T. M., Yoon, S-S., Beksac, M., Dimopoulos, M. A., Elghandour, A., Jedrzejczak, W. W., Günther, A., Nakorn, T. N., Siritanaratkul, N., Corradini, P., Chuncharunee, S., Lee, J-J., Schlossman, R. L., Shelekhova, T., Yong, K., Tan, D., Numbenjapon, T., Cavenagh, J. D., Hou, J., LeBlanc, R., Nahi, H., Qiu, L., Salwender, H., Pulini, S., Moreau, P., Warzocha, K., White, D., Bladé, J., Chen, W., de la Rubia, J., Gimsing, P., Lonial, S., Kaufman, J. L., Ocio, E. M., Veskovski, L., Sohn, S. K., Wang, M-C., Lee, J. H., Einsele, H., Sopala, M., Corrado, C., Bengoudifa, B-R., Binlich, F. & Richardson, P. G., Oct 2014, In: Lancet Oncology. 15, 11, p. 1195-206 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    How safe is a standard-risk child with ALL?

    Winther, J. F. & Schmiegelow, K., Jul 2014, In: Lancet Oncology. 15, 8, p. 782-3 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Enzalutamide monotherpy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study

    Tombal, B., Borre, M., Rathenborg, P., Werbrouck, P., Van Poppel, H., Heidenreich, A., Iversen, P., Braeckman, J., Heracek, J., Baskin-Bey, E., Ouatas, T., Perabo, F., Phung, D., Hirmand, M. & Smith, M. R., 11 Apr 2014, In: The Lancet Oncology. 15, 6, p. 592-600

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. Published

    Radiotherapy for indolent lymphomas: how much is enough?

    Specht, L., Apr 2014, In: Lancet Oncology. 15, 4, p. 372-4 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. 2013
  52. Published

    Hospital contact for mental disorders in survivors of childhood cancer and their siblings in Denmark: a population-based cohort study

    Lund, L. W., Winther, J., Dalton, S. O., Cederkvist, L., Jeppesen, P., Deltour, I., Hargreave, M. L. G., Kjær, S. K., Jensen, A., Rechnitzer, C., Andersen, K., Schmiegelow, K. & Johansen, C., Sep 2013, In: The Lancet Oncology. 14, 10, p. 971-80 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  53. Published

    Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

    Pivot, X., Gligorov, J., Müller, V., Barrett-Lee, P., Verma, S., Knoop, A., Curigliano, G., Semiglazov, V., López-Vivanco, G., Jenkins, V., Scotto, N., Osborne, S., Fallowfield, L. & PrefHer Study Group, Sep 2013, In: The Lancet Oncology. 14, 10, p. 962-70 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  54. Published

    Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

    Sieh, W., Köbel, M., Longacre, T. A., Bowtell, D. D., deFazio, A., Goodman, M. T., Høgdall, E., Deen, S., Wentzensen, N., Moysich, K. B., Brenton, J. D., Clarke, B. A., Menon, U., Gilks, C. B., Kim, A., Madore, J., Fereday, S., George, J., Galletta, L., Lurie, G., Wilkens, L. R., Carney, M. E., Thompson, P. J., Matsuno, R. K., Kjær, S. K., Jensen, A., Høgdall, C., Kalli, K. R., Fridley, B. L., Keeney, G. L., Vierkant, R. A., Cunningham, J. M., Brinton, L. A., Yang, H. P., Sherman, M. E., García-Closas, M., Lissowska, J., Odunsi, K., Morrison, C., Lele, S., Bshara, W., Sucheston, L., Jimenez-Linan, M., Driver, K., Alsop, J., Mack, M., McGuire, V., Rothstein, J. H., Rosen, B. P., Bernardini, M. Q., Mackay, H., Oza, A., Wozniak, E. L., Benjamin, E., Gentry-Maharaj, A., Gayther, S. A., Tinker, A. V., Prentice, L. M., Chow, C., Anglesio, M. S., Johnatty, S. E., Chenevix-Trench, G., Whittemore, A. S., Pharoah, P. D. P., Goode, E. L., Huntsman, D. G. & Ramus, S. J., Aug 2013, In: The Lancet Oncology. 14, 9, p. 853-62 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  55. 2012
  56. Published

    Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

    Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L. R., Carney, M. E., Goodman, M. T., Moysich, K., Kjaer, S. K., Hogdall, E., Jensen, A., Goode, E. L., Fridley, B. L., Larson, M. C., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Vitonis, A. F., Titus, L. J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S. J., Anderson, A. R., Brueggmann, D., Fasching, P. A., Gayther, S. A., Huntsman, D. G., Menon, U., Ness, R. B., Pike, M. C., Risch, H., Wu, A. H., Berchuck, A. & Ovarian Cancer Association Consortium, 2012, In: Lancet Oncology. 13, 4, p. 385-94 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  57. Published

    Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

    Mathers, J. C., Movahedi, M., Macrae, F., Mecklin, J-P., Moeslein, G., Olschwang, S., Eccles, D., Evans, G., Maher, E. R., Bertario, L., Bisgaard, S. M. L., Dunlop, M., Ho, J. W. C., Hodgson, S., Lindblom, A., Lubinski, J., Morrison, P. J., Murday, V., Ramesar, R., Side, L., Scott, R. J., Thomas, H. J. W., Vasen, H., Gerdes, A-M., Barker, G., Crawford, G., Elliott, F., Pylvanainen, K., Wijnen, J., Fodde, R., Lynch, H., Bishop, D. T., Burn, J. & CAPP2 Investigators, 2012, In: Lancet Oncology. 13, 12, p. 1242-9 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  58. Published

    Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC

    Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., Dale, O., De Conno, F., Fallon, M., Hanna, M., Haugen, D. F., Juhl, G., King, S., Klepstad, P., Laugsand, E. A., Maltoni, M., Mercadante, S., Nabal, M., Pigni, A., Radbruch, L., Reid, C., Sjogren, P., Stone, P. C., Tassinari, D., Zeppetella, G. & European Palliative Care Research Collaborative (EPCRC), 2012, In: Lancet Oncology. 13, 2, p. e58-68

    Research output: Contribution to journalJournal articleResearchpeer-review

  59. 2011
  60. Published

    Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

    Regan, M. M., Neven, P., Giobbie-Hurder, A., Goldhirsch, A., Ejlertsen, B., Mauriac, L., Forbes, J. F., Smith, I., Láng, I., Wardley, A., Rabaglio, M., Price, K. N., Gelber, R. D., Coates, A. S., Thürlimann, B. & BIG 1-98 Collaborative Group, Nov 2011, In: Lancet Oncology. 12, 12, p. 1101-8 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 109280